Cargando…

Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke

BACKGROUND: The related factors affecting the adherence of ischemic cerebral stroke (ICS) patients to antiplatelet therapy have attracted much attention. METHODS: Patients with ICS (confirmed by CT or MRI) were enrolled from January 2020 to July 2021. The demographic data were retrospectively invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Jie, Gao, Yuguang, Huang, Deqing, Hu, Yueqiang, He, Qianchao, Diao, Limei, Hu, Yuying, Chen, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175999/ https://www.ncbi.nlm.nih.gov/pubmed/37062920 http://dx.doi.org/10.1002/brb3.2982

Ejemplares similares

Antiplatelet therapy may be safe in ischemic stroke patients with cerebral microbleed
por: Meng, Ningqin, et al.
Publicado: (2020)

Antiplatelet Use in Ischemic Stroke
por: Kamarova, Marharyta, et al.
Publicado: (2022)

Anticoagulation versus Antiplatelet Therapy after Ischemic Stroke in the Patients with Atrial Fibrillation and Cerebral Microbleeds
por: Choi, Kang-Ho, et al.
Publicado: (2021)

Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke
por: Kim, Tae Jung, et al.
Publicado: (2023)

Comorbidity of Pain and Depression in a Lumbar Disc Herniation Model: Biochemical Alterations and the Effects of Fluoxetine
por: Cai, Lun, et al.
Publicado: (2019)

Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review
por: Alhazzani, Adel, et al.
Publicado: (2021)

Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke
por: Xian, Ying, et al.
Publicado: (2022)

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
por: Guo, Yinping, et al.
Publicado: (2021)

Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis
por: Xie, Wuxiang, et al.
Publicado: (2015)

Thromboelastography predicts dual antiplatelet therapy-related hemorrhage in patients with acute ischemic stroke
por: He, Dan, et al.
Publicado: (2022)

Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome
por: Okuma, Hirohisa, et al.
Publicado: (2009)

Dual Antiplatelet Therapy after Noncardioembolic Ischemic Stroke or Transient Ischemic Attack: Pros and Cons
por: Hong, Keun-Sik
Publicado: (2014)

Personalized antiplatelet therapy guided by clopidogrel pharmacogenomics in acute ischemic stroke and transient ischemic attack: A prospective, randomized controlled trial
por: Zhang, Xiaoguang, et al.
Publicado: (2023)

Dual or Mono Antiplatelet Therapy for the Prevention of Ischemic Stroke: A Literature Review
por: Anjum, Ibrar, et al.
Publicado: (2018)

Beyond antiplatelets: The role of glycoprotein VI in ischemic stroke
por: Induruwa, Isuru, et al.
Publicado: (2016)

Effect of Argatroban Combined With Dual Antiplatelet Therapy on Early Neurological Deterioration in Acute Minor Posterior Circulation Ischemic Stroke
por: Zhou, Ling-Shan, et al.
Publicado: (2020)

Pacemaker lead malpositioning led to subsequent ischemic strokes despite antiplatelet and anticoagulation therapy
por: Rath, Claus, et al.
Publicado: (2014)

Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke
por: Hilkens, Nina A., et al.
Publicado: (2018)

Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke
por: Liu, Tingting, et al.
Publicado: (2022)

Antiplatelet Treatment After Transient Ischemic Attack and Ischemic Stroke in Patients With Cerebral Microbleeds in 2 Large Cohorts and an Updated Systematic Review
por: Lau, Kui Kai, et al.
Publicado: (2018)

Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
por: Vališ, Martin, et al.
Publicado: (2021)

Safety and efficacy of short-term dual antiplatelet therapy combined with intensive rosuvastatin in acute ischemic stroke
por: Deng, Ting, et al.
Publicado: (2023)

The Impact of Cerebral Microbleeds Presence on Outcome Following Minor Stroke Treated With Antiplatelet Therapy
por: Sakuta, Kenichi, et al.
Publicado: (2020)

Efficacy and Safety of Anticoagulant Therapy Versus Antiplatelet Therapy in Acute Ischemic Stroke Patients with Atrial Fibrillation
por: Yan, Xiaodi, et al.
Publicado: (2023)

Dual antiplatelet therapy reduced stroke risk in transient ischemic attack with positive diffusion weighted imaging
por: Pei, Lu-lu, et al.
Publicado: (2020)

Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis
por: Li, Xiao‐Qiu, et al.
Publicado: (2022)

Trends in Ambulatory Prescribing of Antiplatelet Therapy among US Ischemic Stroke Patients: 2000–2007
por: Karve, Sudeep, et al.
Publicado: (2012)

Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke
por: Hilkens, Nina A., et al.
Publicado: (2021)

A Case of Failed Dual Antiplatelet Therapy With Oral Anticoagulant in the Prevention of Acute Ischemic Stroke
por: Amoda, Oluyemisi, et al.
Publicado: (2021)

Corrigendum: Factors affecting physician decision-making regarding antiplatelet therapy in minor ischemic stroke
por: Liu, Tingting, et al.
Publicado: (2022)

Platelet function-guided modification in antiplatelet therapy after acute ischemic stroke is associated with clinical outcomes in patients with aspirin nonresponse
por: Yi, Xingyang, et al.
Publicado: (2017)

Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
por: Lin, Chun-Jen, et al.
Publicado: (2022)

The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack
por: McDermott, John H, et al.
Publicado: (2022)

Advances in Our Understanding of “Resistance” to Antiplatelet Agents for Prevention of Ischemic Stroke
por: Gorelick, Philip B., et al.
Publicado: (2013)

Evaluation and subgroup analysis of the efficacy and safety of intensive rosuvastatin therapy combined with dual antiplatelet therapy in patients with acute ischemic stroke
por: Deng, Ting, et al.
Publicado: (2022)

The use of dual antiplatelet therapy for ischemic cerebrovascular events
por: Mele, Francesco, et al.
Publicado: (2022)

Risk of Serious Bleeding with Antiplatelet Therapy for Secondary Prevention Post Ischemic Stroke in Middle East Population
por: Awada, Zeinab, et al.
Publicado: (2019)

Association between antiplatelet medication and cerebral microbleeds in stroke-free population
por: YU, Miao-Xin, et al.
Publicado: (2022)

Precision antiplatelet therapy for the prevention of ischaemic stroke
por: Wang, David
Publicado: (2021)

Curcumin Reduces Neuronal Loss and Inhibits the NLRP3 Inflammasome Activation in an Epileptic Rat Model
por: He, Qianchao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_costle5att3ecje1s5prfbrkg5